萬順新材(300057.SZ):安徽中基以電池鋁箔為主 穩定供應寧德時代等頭部電池企業
格隆匯7月11日丨萬順新材(300057.SZ)近期在接待機構調研時表示,安徽中基以電池鋁箔為主,穩定供應寧德時代等頭部電池企業。總產能規劃17.2萬噸,其中:7.2萬噸高精度電子鋁箔生產項目中一期4萬噸項目於2021年底投產;二期3.2萬噸項目首條軋機已進入調試階段,項目計劃於今年8月份建成;年產10萬噸動力及儲能電池箔項目正在進行工程建設,主設備計劃今年底開始陸續到廠,計劃明年全面完成建設。項目全部建成後,江蘇中基、安徽中基兩個基地將形成25.5萬噸鋁箔總產能。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.